Identify and validate blood borne multi-omics biomarkers to predict people at high risk of developing lung cancer or patients with undiagnosed disease.

We found the biomarkers indicating imminent lung cancer (diagnosis within 1-3 years) are different from long-term risks (diagnosis within 4-10 years). 

Collaborators: John Field, Andy Jones and Ruwanthi Kolamunnage-Dona

CRUK Primer Award Team members: Anand Karpagam, Mike Davies, Jamie Soul, Euan McDonnell, Maria Sudell